This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A significant proportion of patients with severe aorticstenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) have concomitant coronary artery disease (CAD). The best way to treat these patients is contentious.
In these panel discussions, host Andrea Price, MS, AACC brings together Marian Hawkey, RN and Misty Theriot, BSN to explore bestpractices related to structural heart disease.
Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program recently reported it has reached a significant milestone of performing over 5,000 transcatheter aortic valve replacement (TAVR) procedures, the first in New Jersey and among the first to accomplish this in the United States.
In our ongoing commitment to advancing cardiovascular care, ADN CoE recently hosted an intensive Transcatheter Aortic Valve Implantation (TAVI) Training at the prestigious Adana City Health Training and Research Center. They ensure that cardiologists stay at the forefront of technological advancements and bestpractices in the field.
In our ongoing commitment to advancing cardiovascular care, ADN CoE recently hosted an intensive Transcatheter Aortic Valve Implantation (TAVI) Training at the prestigious Adana City Health Training and Research Center. They ensure that cardiologists stay at the forefront of technological advancements and bestpractices in the field.
No doubt ,the Aortic interventional world is applauding and everyone is joining the party. Did the trial compared bestpractices of TAVI & SAVR ? Apart from valve size aortic annular enlargement before SAVR was not done in majority, there by enhancing the gradient and valve mis-match.(Note Reference 1.Hans
Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aorticstenosis. Our goal is to unite specialists from every corner of cardiovascular care to extend the heart team, redefine innovations, and develop new standards for managing valve patients."
Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aorticstenosis. Our goal is to unite specialists from every corner of cardiovascular care to extend the heart team, redefine innovations, and develop new standards for managing valve patients."
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content